MRI Contrast Agents Based on Conjugated Polyelectrolytes and Dendritic Polymers

Area of Science:

• Materials Science
• Nanotechnology
• Medical Imaging

Background:

• Gadolinium-based complexes are crucial as magnetic resonance imaging (MRI) contrast agents.
• Developing novel MRI contrast agents with improved efficacy and safety profiles is an ongoing research area.
• Dendritic molecules offer unique structural properties for designing advanced contrast agents.

Purpose of the Study:

• To synthesize and evaluate novel gadolinium-based dendrimer complexes as MRI contrast agents.
• To investigate the performance of macromolecular MRI contrast agents compared to small molecular ones.
• To assess the cytotoxicity and in vivo clearance pathways of the developed gadolinium complexes.

Main Methods:

• Synthesis of gadolinium complexes with dendritic ligands featuring carboxylate groups.
• Preparation of conjugated polyelectrolytes and dendrimer combinations via coupling polymerization.
• Evaluation of longitudinal relaxivity values and in vitro/in vivo MR imaging enhancement.
• Assessment of cytotoxicity and hepatobiliary clearance in preclinical models.

Main Results:

• The newly designed macromolecular skeleton-based contrast agent exhibited a high longitudinal relaxivity value (36.2 mm^-1 s^-1).
• Enhanced visibility was observed in both in vivo and in vitro MR images compared to small molecular agents.
• The complexes demonstrated extremely low cytotoxicity and primarily cleared via the hepatobiliary system.
• These properties suggest a reduced risk of adverse effects in patients with chronic kidney disease.

Conclusions:

• The developed gadolinium-based dendrimer complexes show significant promise as advanced MRI contrast agents.
• Macromolecular design leads to superior relaxivity and imaging performance.
• Favorable safety profiles, including low cytotoxicity and specific clearance routes, enhance their clinical applicability.